Target intelligence / Profile preview

DUSP5 divergent transcript (DUSP5-DT)

Target
DUSP5-DT
Molecular classification
Other (likely "Non-coding RNA" or "Long non-coding RNA (lncRNA)", though not confirmed in major databases)
01

Overview

DUSP5 divergent transcript (DUSP5-DT, LOC105378482) refers to an annotated genomic transcript near or antisense to DUSP5, but there is currently no evidence that it encodes a functional protein or has established biological or disease relevance. This entity is not recognized as a therapeutic target, nor are any drug interactions or biomarker roles described in the scientific literature. Explanation and context: - DUSP5 encodes dual specificity phosphatase 5, a well-characterized enzyme involved in MAPK/ERK signal regulation and sometimes reported in the context of diseases such as cancer[1][2][3][4][5]. However, "DUSP5 divergent transcript" (DUSP5-DT, LOC105378482) is a different genomic entry, not equivalent to DUSP5. - Divergent transcripts are typically named for their orientation near a gene of interest (here, DUSP5), but most have unclear or uncharacterized functions and do not represent classic therapeutic targets[1]. - There are no known drugs, mechanisms, biomarker uses, or disease associations specifically linked to DUSP5-DT or LOC105378482 in the available literature. - This transcript is not present in major therapeutic target or drug discovery databases, nor is it discussed in published functional genomics or pharmacology studies. - If your query intended to target DUSP5 (the protein-coding enzyme), rather than DUSP5-DT, see the canonical DUSP5 entries for disease, mechanism, and drug-related information[1][2][3][4][5]. Note: This entry appears to be a genomic annotation artifact or a minimally characterized non-coding RNA, not a therapeutic target. If you need information on DUSP5, the enzyme, please clarify the request.

Other names
LOC105378482DUSP5-DT
02

Biological functions

Unknown
03

Disease associations

Unknown

Beyond the preview

Go deeper on DUSP5 divergent transcript (DUSP5-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DUSP5 divergent transcript (DUSP5-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call